Given that GSK3β inhibition increases NOTCH1 signaling and CLL cell survival, and NOTCH1 signaling is oncogenic in CLL [4], we suggest that GSK3β has a tumor suppressor role in CLL. The gene discussed is GSK3B; the disease is B-cell chronic lymphocytic leukemia.